Cheng H - Search Results

1

A comparative high-throughput screening protocol to identify entry inhibitors of enveloped viruses.

Wang J, Cheng H, Ratia K, Varhegyi E, Hendrickson WG, Li J, Rong L. Wang J, et al. Among authors: cheng h. J Biomol Screen. 2014 Jan;19(1):100-7. doi: 10.1177/1087057113494405. Epub 2013 Jul 2. J Biomol Screen. 2014. PMID: 23821643 Free PMC article.

2

Inhibition of Ebola and Marburg Virus Entry by G Protein-Coupled Receptor Antagonists.

Cheng H, Lear-Rooney CM, Johansen L, Varhegyi E, Chen ZW, Olinger GG, Rong L. Cheng H, et al. J Virol. 2015 Oct;89(19):9932-8. doi: 10.1128/JVI.01337-15. Epub 2015 Jul 22. J Virol. 2015. PMID: 26202243 Free PMC article.

3

A High-Throughput Screening Platform Targeting PDLIM5 for Pulmonary Hypertension.

Cheng H, Chen T, Tor M, Park D, Zhou Q, Huang JB, Khatib N, Rong L, Zhou G. Cheng H, et al. J Biomol Screen. 2016 Apr;21(4):333-41. doi: 10.1177/1087057115625924. Epub 2016 Jan 13. J Biomol Screen. 2016. PMID: 26762503

4

A cell-based high-throughput protocol to screen entry inhibitors of highly pathogenic viruses with Traditional Chinese Medicines.

Yang Y, Cheng H, Yan H, Wang PZ, Rong R, Zhang YY, Zhang CB, Du RK, Rong LJ. Yang Y, et al. Among authors: cheng h. J Med Virol. 2017 May;89(5):908-916. doi: 10.1002/jmv.24705. Epub 2016 Oct 14. J Med Virol. 2017. PMID: 27704591 Free PMC article.

5

Identification of entry inhibitors with 4-aminopiperidine scaffold targeting group 1 influenza A virus.

Hussein AFA, Cheng H, Tundup S, Antanasijevic A, Varhegyi E, Perez J, AbdulRahman EM, Elenany MG, Helal S, Caffrey M, Peet N, Manicassamy B, Rong L. Hussein AFA, et al. Among authors: cheng h. Antiviral Res. 2020 May;177:104782. doi: 10.1016/j.antiviral.2020.104782. Epub 2020 Mar 25. Antiviral Res. 2020. PMID: 32222293 Free PMC article.

6

Inhibition of influenza H7 hemagglutinin-mediated entry.

Antanasijevic A, Cheng H, Wardrop DJ, Rong L, Caffrey M. Antanasijevic A, et al. Among authors: cheng h. PLoS One. 2013 Oct 23;8(10):e76363. doi: 10.1371/journal.pone.0076363. eCollection 2013. PLoS One. 2013. PMID: 24194835 Free PMC article.

7

Role of EXT1 and Glycosaminoglycans in the Early Stage of Filovirus Entry.

O'Hearn A, Wang M, Cheng H, Lear-Rooney CM, Koning K, Rumschlag-Booms E, Varhegyi E, Olinger G, Rong L. O'Hearn A, et al. Among authors: cheng h. J Virol. 2015 May;89(10):5441-9. doi: 10.1128/JVI.03689-14. Epub 2015 Mar 4. J Virol. 2015. PMID: 25741008 Free PMC article.

8

A parallel genome-wide RNAi screening strategy to identify host proteins important for entry of Marburg virus and H5N1 influenza virus.

Cheng H, Koning K, O'Hearn A, Wang M, Rumschlag-Booms E, Varhegyi E, Rong L. Cheng H, et al. Virol J. 2015 Nov 24;12:194. doi: 10.1186/s12985-015-0420-3. Virol J. 2015. PMID: 26596270 Free PMC article.

9

Cell-Based High-Throughput Screening Assay Identifies 2',2'-Difluoro-2'-deoxycytidine Gemcitabine as a Potential Antipoliovirus Agent.

Zhang Z, Yang E, Hu C, Cheng H, Chen CY, Huang D, Wang R, Zhao Y, Rong L, Vignuzzi M, Shen H, Shen L, Chen ZW. Zhang Z, et al. Among authors: cheng h. ACS Infect Dis. 2017 Jan 13;3(1):45-53. doi: 10.1021/acsinfecdis.6b00116. Epub 2016 Nov 11. ACS Infect Dis. 2017. PMID: 27733043 Free PMC article.

10

Identification of a coumarin-based antihistamine-like small molecule as an anti-filoviral entry inhibitor.

Cheng H, Schafer A, Soloveva V, Gharaibeh D, Kenny T, Retterer C, Zamani R, Bavari S, Peet NP, Rong L. Cheng H, et al. Antiviral Res. 2017 Sep;145:24-32. doi: 10.1016/j.antiviral.2017.06.015. Epub 2017 Jun 20. Antiviral Res. 2017. PMID: 28645623 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16,836 results

Search Page

Filters